A Randomized Crossover Study to Determine the bioequivalence of Three Consecutive Daily Doses of Oraxol in Cancer Patients Treated with Intravenous Paclitaxel

  • Segelov, Eva (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date8/02/19 → 7/02/24

Clinical Trial Phase

  • Phase I